title: Internalization and phagosome escape required for Francisella to induce human monocyte IL-1beta processing and release.
abstract: Macrophage responses to Francisella infection have been characterized previously by subdued proinflammatory responses; however, these studies have generally focused on macrophage cell lines or monocyte-derived macrophages. Therefore, we studied the ability of fresh human blood monocytes to engulf and respond to Francisella by using the live vaccine strain variant and Francisella novicida. Because Francisella organisms have been reported to escape from the phagolysosome into the cytosol, we hypothesized that this escape may trigger the activation of caspase-1. Francisella tularensis variants were readily taken up by fresh human CD14(+) monocytes, inducing the release of IL-1beta, as well as IL-8, in a time- and dose-dependent fashion. Importantly, whereas live and dead Escherichia coli, F. novicida, and live vaccine strain, as well as the LPS of E. coli, were able to induce abundant IL-1beta mRNA synthesis and intracellular pro-IL-1beta production, only live Francisella induced enhanced IL-1beta processing and release (51 +/- 10 vs. 7.1 +/- 2.1 ng/ml, for F. novicida vs. E. coli LPS; P = 0.0032). Cytochalasin D blocked the Francisella internalization and the Francisella-induced monocyte IL-1beta processing and release but not that induced by the exogenous stimulus E. coli LPS. Also, killing bacteria did not block uptake but significantly diminished the IL-1beta processing and release that was induced by Francisella. Blocking bacterial escape from the phagosome into the cytosol also decreased IL-1beta but not IL-8 release. These findings demonstrate that Francisella organisms efficiently induce IL-1beta processing and release in fresh monocytes by means of a sensing system that requires the uptake of live bacteria capable of phagosome escape.
authors.affiliation: Davis Heart and Lung Research Institute, Department of Molecular Virology and Immunology and Medical Genetics, and Center for Microbial Interface Biology, Ohio State University, Columbus, OH 43210, USA.
authors.forename: Mikhail A
authors.initials: MA
authors.lastname: Gavrilin
authors.forename: Imad J
authors.initials: IJ
authors.lastname: Bouakl
authors.forename: Nina L
authors.initials: NL
authors.lastname: Knatz
authors.forename: Michelle D
authors.initials: MD
authors.lastname: Duncan
authors.forename: Mark W
authors.initials: MW
authors.lastname: Hall
authors.forename: John S
authors.initials: JS
authors.lastname: Gunn
authors.forename: Mark D
authors.initials: MD
authors.lastname: Wewers
mesh_terms: D015638:Cytochalasin D / Q000494:pharmacology; D004926:Escherichia coli / Q000276:immunology; D005603:Francisella / Q000276:immunology*; D016905:Gram-Negative Bacterial Infections / Q000276:immunology*; D006801:Humans; D007375:Interleukin-1 / Q000276:immunology / Q000378:metabolism*; D016209:Interleukin-8 / Q000276:immunology / Q000378:metabolism; D008070:Lipopolysaccharides; D008856:Microscopy, Fluorescence; D009000:Monocytes / Q000276:immunology*; D010587:Phagocytosis / Q000187:drug effects / Q000276:immunology*; D010588:Phagosomes / Q000378:metabolism; D016133:Polymerase Chain Reaction
chemical_list: D007375:Interleukin-1; D016209:Interleukin-8; D008070:Lipopolysaccharides; D015638:Cytochalasin D